Nanobodies Market - Global Industry Insights, Trends, Outlook, and Analysis, 2018-2026

1. Nanobodies Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Nanobodies Market – Overview Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. These technology was developed from antigen binding fragments, originating from Camelid heavy- chain antibodies. These molecules do not have light chains, which is an essential part of antibody found in humans. Based on the above finding, nanobodies molecule containing single-domain only were developed, and these molecules contain functional and structural properties similar to heavy chain antibodies. These molecules have several advantages as compared to the conventional antibodies such as small-size, nano to picomolar affinities, and multiple route of administration. Ablynx, which is acquired by Sanofi S.A., is one of the leading company in this market. Currently, no products are available in the market, but there are multiple products in the pipeline including few in very late stage of clinical trials. For instance, marketing authorization application for Caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) has been submitted to European Medicine Agency (EMA) in February 2017. The product, Caplacizumab, is expected to be launched in Europe in 2018. Moreover, the company, Ablynx, is expected to file for biologic license agreement to the U.S. Food and Drug Administration (FDA) in 2018, and is expected to launch this product in U.S. in 2019. Both, Europe and U.S. are the key markets for any biologics including monoclonal antibodies and are expected to be the high revenue generating market for nanobodies. © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Nanobodies Market Taxonomy: Nanobodies Market Taxonomy: By Product Type: By Product Type: Mono-specific Mono-specific ● ● Monovalent Monovalent ● ● Multivalent Multivalent ● ● Bi-paratopic Bi-paratopic ● ● Multi-specific Multi-specific ● ● By Indication: By Indication: Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Acquired Thrombotic Thrombocytopenic Purpura (aTTP) ● ● Respiratory Syncytial Virus (RSV) Infection Respiratory Syncytial Virus (RSV) Infection ● ● Rheumatoid Arthritis Rheumatoid Arthritis ● ● Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1680 Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1680 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Nanobodies Market: Key Players Ablynx (now part of Sanofi S. A. ● Novo Nordisk A/S, ● Merck & Co., Inc., ● Merck KGaA, ● AbbVie, Inc., and ● C.H. Boehringer Sohn AG & Ko. KG. ● View this report @ https://www.coherentmarketinsights.com/ongoing-insight/nanobodies-market-1680 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES Chemicals & Materials Speciality and Fine Chemicals Advanced Materials Bulk Chemicals Green Chemicals Polymers & Resins Food Ingredients Cosmetic Ingredients © Coherent market Insights. All Rights Reserved

7. ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARC H EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. T o know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentm arketinsights.com THANK YOU For other queries contact: Mr. Shah (M anager - Business Development) C oherent Market Insights sales@coherentm arketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved